Top Story

Cedars-Sinai names deputy director of integrated oncology

Cedars-Sinai names deputy director of integrated oncology
October 23, 2016

Robert A. Figlin, MD, has been named deputy director of the integrated oncology service line at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.

Figlin — who previously served as director of the hematology–oncology division at the institute — will work with investigators and clinicians to unify the health system’s approach to treating cancer by integrating research and clinical strategies.

Radiation Oncology Institute awards two grants

October 22, 2016
The Radiation Oncology Institute selected two researchers to receive Innovative Projects in Radiation Oncology grant awards. The awards, which total nearly $100,000…

ICER council votes on effectiveness, value of NSCLC therapies

October 21, 2016
The Midwest Comparative Effectiveness Public Advisory Council program of the Institute for Clinical and Economic Review yesterday generally voted in favor of the…
In the Journals Plus

Health insurance expansion may increase access to colorectal cancer care

October 21, 2016
A 2006 Massachusetts health care reform that served as a model for the Affordable Care Act increased rates of resection and decreased probability of emergent resection…

ACR asks for FDA guidelines on biosimilar substitution

October 21, 2016
During a public meeting on the reauthorization of the Biosimilar User Free Act, Angus Worthing, MD, FACR, FACP, incoming chair of the American College of…
More News Headlines »

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Meeting News Coverage

VIDEO: Less surgery, active surveillance viable option for low-risk thyroid cancer

September 22, 2016
More »

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Current Issues
View the Current Issue
HemOnc Today